nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—CYP2D6—Temsirolimus—kidney cancer	0.138	0.372	CbGbCtD
Dexmethylphenidate—CYP2D6—Pazopanib—kidney cancer	0.0724	0.195	CbGbCtD
Dexmethylphenidate—CYP2D6—Erlotinib—kidney cancer	0.0517	0.139	CbGbCtD
Dexmethylphenidate—CYP2D6—Sorafenib—kidney cancer	0.042	0.113	CbGbCtD
Dexmethylphenidate—CYP2D6—Vinblastine—kidney cancer	0.0415	0.112	CbGbCtD
Dexmethylphenidate—CYP2D6—Doxorubicin—kidney cancer	0.0255	0.0687	CbGbCtD
Dexmethylphenidate—Cyclopentolate—BCHE—kidney cancer	0.00113	1	CrCbGaD
Dexmethylphenidate—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—kidney cancer	0.000641	0.0737	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—kidney cancer	0.000558	0.0642	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Dopaminergic Neurogenesis—ALDH1A1—kidney cancer	0.000379	0.0435	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Parkinsons Disease Pathway—LRRK2—kidney cancer	0.000329	0.0378	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000293	0.0337	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Monoamine Transport—ACHE—kidney cancer	0.000277	0.0319	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Monoamine Transport—ACHE—kidney cancer	0.000239	0.0274	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Parkinsons Disease Pathway—CASP2—kidney cancer	0.000238	0.0273	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Parkinsons Disease Pathway—APAF1—kidney cancer	0.000223	0.0257	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Monoamine Transport—ACHE—kidney cancer	0.000211	0.0243	CbGpPWpGaD
Dexmethylphenidate—Constipation—Gemcitabine—kidney cancer	0.000203	0.000328	CcSEcCtD
Dexmethylphenidate—Nausea—Erlotinib—kidney cancer	0.000203	0.000328	CcSEcCtD
Dexmethylphenidate—Alopecia—Capecitabine—kidney cancer	0.000203	0.000327	CcSEcCtD
Dexmethylphenidate—Dry mouth—Paclitaxel—kidney cancer	0.000203	0.000327	CcSEcCtD
Dexmethylphenidate—Mood swings—Doxorubicin—kidney cancer	0.000203	0.000327	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Sunitinib—kidney cancer	0.000202	0.000327	CcSEcCtD
Dexmethylphenidate—Mental disorder—Capecitabine—kidney cancer	0.000201	0.000325	CcSEcCtD
Dexmethylphenidate—Asthenia—Dactinomycin—kidney cancer	0.000201	0.000324	CcSEcCtD
Dexmethylphenidate—Confusional state—Paclitaxel—kidney cancer	0.0002	0.000323	CcSEcCtD
Dexmethylphenidate—Malnutrition—Capecitabine—kidney cancer	0.0002	0.000323	CcSEcCtD
Dexmethylphenidate—Erythema—Capecitabine—kidney cancer	0.0002	0.000323	CcSEcCtD
Dexmethylphenidate—Dehydration—Doxorubicin—kidney cancer	0.000199	0.000321	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Paclitaxel—kidney cancer	0.000199	0.000321	CcSEcCtD
Dexmethylphenidate—Oedema—Paclitaxel—kidney cancer	0.000199	0.000321	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Vincristine—kidney cancer	0.000198	0.000319	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Vincristine—kidney cancer	0.000198	0.000319	CcSEcCtD
Dexmethylphenidate—Liver function test abnormal—Doxorubicin—kidney cancer	0.000197	0.000319	CcSEcCtD
Dexmethylphenidate—Infection—Paclitaxel—kidney cancer	0.000197	0.000319	CcSEcCtD
Dexmethylphenidate—CYP2D6—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000197	0.0226	CbGpPWpGaD
Dexmethylphenidate—Dizziness—Sunitinib—kidney cancer	0.000196	0.000316	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Gemcitabine—kidney cancer	0.000196	0.000316	CcSEcCtD
Dexmethylphenidate—Shock—Paclitaxel—kidney cancer	0.000195	0.000316	CcSEcCtD
Dexmethylphenidate—Vomiting—Sorafenib—kidney cancer	0.000195	0.000315	CcSEcCtD
Dexmethylphenidate—Abdominal pain upper—Doxorubicin—kidney cancer	0.000195	0.000315	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Paclitaxel—kidney cancer	0.000195	0.000315	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Paclitaxel—kidney cancer	0.000194	0.000314	CcSEcCtD
Dexmethylphenidate—Tachycardia—Paclitaxel—kidney cancer	0.000194	0.000313	CcSEcCtD
Dexmethylphenidate—Rash—Sorafenib—kidney cancer	0.000194	0.000313	CcSEcCtD
Dexmethylphenidate—Dermatitis—Sorafenib—kidney cancer	0.000194	0.000313	CcSEcCtD
Dexmethylphenidate—Back pain—Capecitabine—kidney cancer	0.000193	0.000312	CcSEcCtD
Dexmethylphenidate—Breast disorder—Doxorubicin—kidney cancer	0.000193	0.000312	CcSEcCtD
Dexmethylphenidate—Skin disorder—Paclitaxel—kidney cancer	0.000193	0.000312	CcSEcCtD
Dexmethylphenidate—Headache—Sorafenib—kidney cancer	0.000192	0.000311	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Capecitabine—kidney cancer	0.000192	0.00031	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Paclitaxel—kidney cancer	0.000192	0.00031	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Dactinomycin—kidney cancer	0.000192	0.000309	CcSEcCtD
Dexmethylphenidate—Nasopharyngitis—Doxorubicin—kidney cancer	0.000191	0.000309	CcSEcCtD
Dexmethylphenidate—Anorexia—Paclitaxel—kidney cancer	0.000189	0.000306	CcSEcCtD
Dexmethylphenidate—Gastritis—Doxorubicin—kidney cancer	0.000189	0.000306	CcSEcCtD
Dexmethylphenidate—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000189	0.000304	CcSEcCtD
Dexmethylphenidate—Vision blurred—Capecitabine—kidney cancer	0.000188	0.000304	CcSEcCtD
Dexmethylphenidate—Vomiting—Sunitinib—kidney cancer	0.000188	0.000304	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Gemcitabine—kidney cancer	0.000188	0.000303	CcSEcCtD
Dexmethylphenidate—Tremor—Capecitabine—kidney cancer	0.000187	0.000302	CcSEcCtD
Dexmethylphenidate—Rash—Sunitinib—kidney cancer	0.000186	0.000301	CcSEcCtD
Dexmethylphenidate—Dermatitis—Sunitinib—kidney cancer	0.000186	0.000301	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Capecitabine—kidney cancer	0.000185	0.000299	CcSEcCtD
Dexmethylphenidate—Headache—Sunitinib—kidney cancer	0.000185	0.000299	CcSEcCtD
Dexmethylphenidate—Influenza—Doxorubicin—kidney cancer	0.000185	0.000298	CcSEcCtD
Dexmethylphenidate—Asthma—Doxorubicin—kidney cancer	0.000185	0.000298	CcSEcCtD
Dexmethylphenidate—Anaemia—Capecitabine—kidney cancer	0.000185	0.000298	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Vincristine—kidney cancer	0.000184	0.000298	CcSEcCtD
Dexmethylphenidate—Nausea—Sorafenib—kidney cancer	0.000183	0.000295	CcSEcCtD
Dexmethylphenidate—Pancreatitis—Doxorubicin—kidney cancer	0.000181	0.000293	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000181	0.000292	CcSEcCtD
Dexmethylphenidate—Malaise—Capecitabine—kidney cancer	0.00018	0.000291	CcSEcCtD
Dexmethylphenidate—Angina pectoris—Doxorubicin—kidney cancer	0.00018	0.000291	CcSEcCtD
Dexmethylphenidate—Insomnia—Paclitaxel—kidney cancer	0.00018	0.00029	CcSEcCtD
Dexmethylphenidate—Vertigo—Capecitabine—kidney cancer	0.000179	0.00029	CcSEcCtD
Dexmethylphenidate—Asthenia—Vincristine—kidney cancer	0.000179	0.00029	CcSEcCtD
Dexmethylphenidate—Syncope—Capecitabine—kidney cancer	0.000179	0.000289	CcSEcCtD
Dexmethylphenidate—Leukopenia—Capecitabine—kidney cancer	0.000179	0.000289	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Paclitaxel—kidney cancer	0.000178	0.000288	CcSEcCtD
Dexmethylphenidate—Vomiting—Dactinomycin—kidney cancer	0.000178	0.000287	CcSEcCtD
Dexmethylphenidate—Bronchitis—Doxorubicin—kidney cancer	0.000178	0.000287	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Paclitaxel—kidney cancer	0.000177	0.000286	CcSEcCtD
Dexmethylphenidate—Somnolence—Paclitaxel—kidney cancer	0.000177	0.000285	CcSEcCtD
Dexmethylphenidate—Palpitations—Capecitabine—kidney cancer	0.000177	0.000285	CcSEcCtD
Dexmethylphenidate—Rash—Dactinomycin—kidney cancer	0.000176	0.000285	CcSEcCtD
Dexmethylphenidate—Nausea—Sunitinib—kidney cancer	0.000176	0.000284	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Capecitabine—kidney cancer	0.000176	0.000283	CcSEcCtD
Dexmethylphenidate—Pancytopenia—Doxorubicin—kidney cancer	0.000175	0.000283	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Paclitaxel—kidney cancer	0.000175	0.000282	CcSEcCtD
Dexmethylphenidate—Cough—Capecitabine—kidney cancer	0.000174	0.000281	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Paclitaxel—kidney cancer	0.000173	0.000279	CcSEcCtD
Dexmethylphenidate—Hypertension—Capecitabine—kidney cancer	0.000172	0.000278	CcSEcCtD
Dexmethylphenidate—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000172	0.000277	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000171	0.000277	CcSEcCtD
Dexmethylphenidate—Fatigue—Paclitaxel—kidney cancer	0.000171	0.000277	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Vincristine—kidney cancer	0.000171	0.000276	CcSEcCtD
Dexmethylphenidate—Asthenia—Gemcitabine—kidney cancer	0.00017	0.000275	CcSEcCtD
Dexmethylphenidate—Myalgia—Capecitabine—kidney cancer	0.00017	0.000275	CcSEcCtD
Dexmethylphenidate—Chest pain—Capecitabine—kidney cancer	0.00017	0.000275	CcSEcCtD
Dexmethylphenidate—Arthralgia—Capecitabine—kidney cancer	0.00017	0.000275	CcSEcCtD
Dexmethylphenidate—Constipation—Paclitaxel—kidney cancer	0.00017	0.000274	CcSEcCtD
Dexmethylphenidate—Pain—Paclitaxel—kidney cancer	0.00017	0.000274	CcSEcCtD
Dexmethylphenidate—Anxiety—Capecitabine—kidney cancer	0.000169	0.000274	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000169	0.000273	CcSEcCtD
Dexmethylphenidate—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000169	0.000272	CcSEcCtD
Dexmethylphenidate—Weight increased—Doxorubicin—kidney cancer	0.000168	0.000272	CcSEcCtD
Dexmethylphenidate—Discomfort—Capecitabine—kidney cancer	0.000168	0.000271	CcSEcCtD
Dexmethylphenidate—Pruritus—Gemcitabine—kidney cancer	0.000168	0.000271	CcSEcCtD
Dexmethylphenidate—Weight decreased—Doxorubicin—kidney cancer	0.000167	0.00027	CcSEcCtD
Dexmethylphenidate—Dry mouth—Capecitabine—kidney cancer	0.000166	0.000269	CcSEcCtD
Dexmethylphenidate—Nausea—Dactinomycin—kidney cancer	0.000166	0.000268	CcSEcCtD
Dexmethylphenidate—Pneumonia—Doxorubicin—kidney cancer	0.000166	0.000268	CcSEcCtD
Dexmethylphenidate—Dizziness—Vincristine—kidney cancer	0.000165	0.000267	CcSEcCtD
Dexmethylphenidate—Drowsiness—Doxorubicin—kidney cancer	0.000165	0.000266	CcSEcCtD
Dexmethylphenidate—Infestation NOS—Doxorubicin—kidney cancer	0.000165	0.000266	CcSEcCtD
Dexmethylphenidate—Infestation—Doxorubicin—kidney cancer	0.000165	0.000266	CcSEcCtD
Dexmethylphenidate—Confusional state—Capecitabine—kidney cancer	0.000164	0.000265	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Paclitaxel—kidney cancer	0.000164	0.000264	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000163	0.000264	CcSEcCtD
Dexmethylphenidate—Oedema—Capecitabine—kidney cancer	0.000163	0.000263	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000162	0.000262	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Gemcitabine—kidney cancer	0.000162	0.000262	CcSEcCtD
Dexmethylphenidate—Infection—Capecitabine—kidney cancer	0.000162	0.000261	CcSEcCtD
Dexmethylphenidate—Shock—Capecitabine—kidney cancer	0.00016	0.000259	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.00016	0.0184	CbGpPWpGaD
Dexmethylphenidate—Conjunctivitis—Doxorubicin—kidney cancer	0.00016	0.000259	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Capecitabine—kidney cancer	0.00016	0.000258	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Capecitabine—kidney cancer	0.00016	0.000258	CcSEcCtD
Dexmethylphenidate—Tachycardia—Capecitabine—kidney cancer	0.000159	0.000257	CcSEcCtD
Dexmethylphenidate—Vomiting—Vincristine—kidney cancer	0.000159	0.000257	CcSEcCtD
Dexmethylphenidate—Skin disorder—Capecitabine—kidney cancer	0.000158	0.000256	CcSEcCtD
Dexmethylphenidate—Sweating—Doxorubicin—kidney cancer	0.000158	0.000255	CcSEcCtD
Dexmethylphenidate—Urticaria—Paclitaxel—kidney cancer	0.000158	0.000255	CcSEcCtD
Dexmethylphenidate—Rash—Vincristine—kidney cancer	0.000158	0.000255	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Capecitabine—kidney cancer	0.000158	0.000254	CcSEcCtD
Dexmethylphenidate—Dermatitis—Vincristine—kidney cancer	0.000158	0.000254	CcSEcCtD
Dexmethylphenidate—Haematuria—Doxorubicin—kidney cancer	0.000157	0.000254	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Paclitaxel—kidney cancer	0.000157	0.000254	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Paclitaxel—kidney cancer	0.000157	0.000254	CcSEcCtD
Dexmethylphenidate—Headache—Vincristine—kidney cancer	0.000157	0.000253	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000156	0.000252	CcSEcCtD
Dexmethylphenidate—Epistaxis—Doxorubicin—kidney cancer	0.000155	0.000251	CcSEcCtD
Dexmethylphenidate—Anorexia—Capecitabine—kidney cancer	0.000155	0.000251	CcSEcCtD
Dexmethylphenidate—Sinusitis—Doxorubicin—kidney cancer	0.000155	0.00025	CcSEcCtD
Dexmethylphenidate—Vomiting—Gemcitabine—kidney cancer	0.000151	0.000244	CcSEcCtD
Dexmethylphenidate—Bradycardia—Doxorubicin—kidney cancer	0.000151	0.000243	CcSEcCtD
Dexmethylphenidate—Rash—Gemcitabine—kidney cancer	0.00015	0.000242	CcSEcCtD
Dexmethylphenidate—Dermatitis—Gemcitabine—kidney cancer	0.000149	0.000241	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Doxorubicin—kidney cancer	0.000149	0.00024	CcSEcCtD
Dexmethylphenidate—Headache—Gemcitabine—kidney cancer	0.000149	0.00024	CcSEcCtD
Dexmethylphenidate—SLC6A4—Monoamine Transport—TSC2—kidney cancer	0.000149	0.0171	CbGpPWpGaD
Dexmethylphenidate—Nausea—Vincristine—kidney cancer	0.000149	0.00024	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000149	0.00024	CcSEcCtD
Dexmethylphenidate—Rhinitis—Doxorubicin—kidney cancer	0.000148	0.000239	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Doxorubicin—kidney cancer	0.000148	0.000239	CcSEcCtD
Dexmethylphenidate—Insomnia—Capecitabine—kidney cancer	0.000147	0.000238	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Doxorubicin—kidney cancer	0.000147	0.000237	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Capecitabine—kidney cancer	0.000146	0.000236	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Paclitaxel—kidney cancer	0.000146	0.000236	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Doxorubicin—kidney cancer	0.000146	0.000236	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Doxorubicin—kidney cancer	0.000145	0.000235	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Capecitabine—kidney cancer	0.000145	0.000235	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Doxorubicin—kidney cancer	0.000145	0.000234	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Capecitabine—kidney cancer	0.000143	0.000232	CcSEcCtD
Dexmethylphenidate—Visual impairment—Doxorubicin—kidney cancer	0.000143	0.00023	CcSEcCtD
Dexmethylphenidate—Asthenia—Paclitaxel—kidney cancer	0.000143	0.00023	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000142	0.0163	CbGpPWpGaD
Dexmethylphenidate—Decreased appetite—Capecitabine—kidney cancer	0.000142	0.000229	CcSEcCtD
Dexmethylphenidate—Nausea—Gemcitabine—kidney cancer	0.000141	0.000228	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000141	0.000227	CcSEcCtD
Dexmethylphenidate—Fatigue—Capecitabine—kidney cancer	0.000141	0.000227	CcSEcCtD
Dexmethylphenidate—Pruritus—Paclitaxel—kidney cancer	0.000141	0.000227	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Doxorubicin—kidney cancer	0.00014	0.000226	CcSEcCtD
Dexmethylphenidate—Constipation—Capecitabine—kidney cancer	0.000139	0.000225	CcSEcCtD
Dexmethylphenidate—Pain—Capecitabine—kidney cancer	0.000139	0.000225	CcSEcCtD
Dexmethylphenidate—Eye disorder—Doxorubicin—kidney cancer	0.000138	0.000223	CcSEcCtD
Dexmethylphenidate—Flushing—Doxorubicin—kidney cancer	0.000137	0.000222	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Doxorubicin—kidney cancer	0.000137	0.000222	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Paclitaxel—kidney cancer	0.000136	0.000219	CcSEcCtD
Dexmethylphenidate—SLC6A4—NRF2 pathway—SLC5A3—kidney cancer	0.000134	0.0154	CbGpPWpGaD
Dexmethylphenidate—Feeling abnormal—Capecitabine—kidney cancer	0.000134	0.000217	CcSEcCtD
Dexmethylphenidate—Angiopathy—Doxorubicin—kidney cancer	0.000134	0.000217	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Doxorubicin—kidney cancer	0.000134	0.000216	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Capecitabine—kidney cancer	0.000133	0.000215	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Doxorubicin—kidney cancer	0.000133	0.000215	CcSEcCtD
Dexmethylphenidate—Chills—Doxorubicin—kidney cancer	0.000133	0.000214	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Doxorubicin—kidney cancer	0.000132	0.000213	CcSEcCtD
Dexmethylphenidate—Dizziness—Paclitaxel—kidney cancer	0.000131	0.000212	CcSEcCtD
Dexmethylphenidate—Alopecia—Doxorubicin—kidney cancer	0.000131	0.000211	CcSEcCtD
Dexmethylphenidate—Mental disorder—Doxorubicin—kidney cancer	0.00013	0.000209	CcSEcCtD
Dexmethylphenidate—Urticaria—Capecitabine—kidney cancer	0.000129	0.000209	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Capecitabine—kidney cancer	0.000129	0.000208	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Capecitabine—kidney cancer	0.000129	0.000208	CcSEcCtD
Dexmethylphenidate—Erythema—Doxorubicin—kidney cancer	0.000129	0.000208	CcSEcCtD
Dexmethylphenidate—Malnutrition—Doxorubicin—kidney cancer	0.000129	0.000208	CcSEcCtD
Dexmethylphenidate—SLC6A2—Monoamine Transport—TSC2—kidney cancer	0.000128	0.0147	CbGpPWpGaD
Dexmethylphenidate—Tension—Doxorubicin—kidney cancer	0.000126	0.000204	CcSEcCtD
Dexmethylphenidate—Vomiting—Paclitaxel—kidney cancer	0.000126	0.000204	CcSEcCtD
Dexmethylphenidate—Rash—Paclitaxel—kidney cancer	0.000125	0.000202	CcSEcCtD
Dexmethylphenidate—Dermatitis—Paclitaxel—kidney cancer	0.000125	0.000202	CcSEcCtD
Dexmethylphenidate—Nervousness—Doxorubicin—kidney cancer	0.000125	0.000202	CcSEcCtD
Dexmethylphenidate—Back pain—Doxorubicin—kidney cancer	0.000125	0.000201	CcSEcCtD
Dexmethylphenidate—Headache—Paclitaxel—kidney cancer	0.000124	0.000201	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Doxorubicin—kidney cancer	0.000124	0.0002	CcSEcCtD
Dexmethylphenidate—Vision blurred—Doxorubicin—kidney cancer	0.000121	0.000196	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Capecitabine—kidney cancer	0.00012	0.000194	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Doxorubicin—kidney cancer	0.000119	0.000193	CcSEcCtD
Dexmethylphenidate—Anaemia—Doxorubicin—kidney cancer	0.000119	0.000192	CcSEcCtD
Dexmethylphenidate—Agitation—Doxorubicin—kidney cancer	0.000118	0.000191	CcSEcCtD
Dexmethylphenidate—Nausea—Paclitaxel—kidney cancer	0.000118	0.000191	CcSEcCtD
Dexmethylphenidate—SLC6A4—NRF2 pathway—KEAP1—kidney cancer	0.000117	0.0135	CbGpPWpGaD
Dexmethylphenidate—Asthenia—Capecitabine—kidney cancer	0.000117	0.000189	CcSEcCtD
Dexmethylphenidate—Malaise—Doxorubicin—kidney cancer	0.000116	0.000187	CcSEcCtD
Dexmethylphenidate—Vertigo—Doxorubicin—kidney cancer	0.000116	0.000187	CcSEcCtD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC5A3—kidney cancer	0.000116	0.0133	CbGpPWpGaD
Dexmethylphenidate—Syncope—Doxorubicin—kidney cancer	0.000115	0.000186	CcSEcCtD
Dexmethylphenidate—Pruritus—Capecitabine—kidney cancer	0.000115	0.000186	CcSEcCtD
Dexmethylphenidate—Leukopenia—Doxorubicin—kidney cancer	0.000115	0.000186	CcSEcCtD
Dexmethylphenidate—Palpitations—Doxorubicin—kidney cancer	0.000114	0.000184	CcSEcCtD
Dexmethylphenidate—SLC6A3—Monoamine Transport—TSC2—kidney cancer	0.000113	0.013	CbGpPWpGaD
Dexmethylphenidate—Loss of consciousness—Doxorubicin—kidney cancer	0.000113	0.000183	CcSEcCtD
Dexmethylphenidate—Cough—Doxorubicin—kidney cancer	0.000112	0.000181	CcSEcCtD
Dexmethylphenidate—Convulsion—Doxorubicin—kidney cancer	0.000112	0.00018	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Capecitabine—kidney cancer	0.000112	0.00018	CcSEcCtD
Dexmethylphenidate—Hypertension—Doxorubicin—kidney cancer	0.000111	0.000179	CcSEcCtD
Dexmethylphenidate—Arthralgia—Doxorubicin—kidney cancer	0.00011	0.000177	CcSEcCtD
Dexmethylphenidate—Chest pain—Doxorubicin—kidney cancer	0.00011	0.000177	CcSEcCtD
Dexmethylphenidate—Myalgia—Doxorubicin—kidney cancer	0.00011	0.000177	CcSEcCtD
Dexmethylphenidate—Anxiety—Doxorubicin—kidney cancer	0.000109	0.000176	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000109	0.000176	CcSEcCtD
Dexmethylphenidate—Discomfort—Doxorubicin—kidney cancer	0.000108	0.000175	CcSEcCtD
Dexmethylphenidate—Dizziness—Capecitabine—kidney cancer	0.000108	0.000174	CcSEcCtD
Dexmethylphenidate—Dry mouth—Doxorubicin—kidney cancer	0.000107	0.000173	CcSEcCtD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—ACHE—kidney cancer	0.000107	0.0123	CbGpPWpGaD
Dexmethylphenidate—Confusional state—Doxorubicin—kidney cancer	0.000106	0.000171	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Doxorubicin—kidney cancer	0.000105	0.00017	CcSEcCtD
Dexmethylphenidate—Oedema—Doxorubicin—kidney cancer	0.000105	0.00017	CcSEcCtD
Dexmethylphenidate—Infection—Doxorubicin—kidney cancer	0.000104	0.000169	CcSEcCtD
Dexmethylphenidate—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000104	0.012	CbGpPWpGaD
Dexmethylphenidate—Vomiting—Capecitabine—kidney cancer	0.000104	0.000167	CcSEcCtD
Dexmethylphenidate—Shock—Doxorubicin—kidney cancer	0.000103	0.000167	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Doxorubicin—kidney cancer	0.000103	0.000166	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Doxorubicin—kidney cancer	0.000103	0.000166	CcSEcCtD
Dexmethylphenidate—Rash—Capecitabine—kidney cancer	0.000103	0.000166	CcSEcCtD
Dexmethylphenidate—Dermatitis—Capecitabine—kidney cancer	0.000103	0.000166	CcSEcCtD
Dexmethylphenidate—Tachycardia—Doxorubicin—kidney cancer	0.000103	0.000166	CcSEcCtD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC5A3—kidney cancer	0.000102	0.0118	CbGpPWpGaD
Dexmethylphenidate—Headache—Capecitabine—kidney cancer	0.000102	0.000165	CcSEcCtD
Dexmethylphenidate—Skin disorder—Doxorubicin—kidney cancer	0.000102	0.000165	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Doxorubicin—kidney cancer	0.000102	0.000164	CcSEcCtD
Dexmethylphenidate—SLC6A2—NRF2 pathway—KEAP1—kidney cancer	0.000101	0.0116	CbGpPWpGaD
Dexmethylphenidate—Anorexia—Doxorubicin—kidney cancer	0.0001	0.000162	CcSEcCtD
Dexmethylphenidate—Nausea—Capecitabine—kidney cancer	9.68e-05	0.000156	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	9.57e-05	0.000155	CcSEcCtD
Dexmethylphenidate—Insomnia—Doxorubicin—kidney cancer	9.5e-05	0.000153	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—HSPD1—kidney cancer	9.47e-05	0.0109	CbGpPWpGaD
Dexmethylphenidate—Paraesthesia—Doxorubicin—kidney cancer	9.43e-05	0.000152	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Doxorubicin—kidney cancer	9.37e-05	0.000151	CcSEcCtD
Dexmethylphenidate—Somnolence—Doxorubicin—kidney cancer	9.34e-05	0.000151	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Doxorubicin—kidney cancer	9.25e-05	0.000149	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Doxorubicin—kidney cancer	9.13e-05	0.000147	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.07e-05	0.000146	CcSEcCtD
Dexmethylphenidate—Fatigue—Doxorubicin—kidney cancer	9.06e-05	0.000146	CcSEcCtD
Dexmethylphenidate—Constipation—Doxorubicin—kidney cancer	8.99e-05	0.000145	CcSEcCtD
Dexmethylphenidate—Pain—Doxorubicin—kidney cancer	8.99e-05	0.000145	CcSEcCtD
Dexmethylphenidate—SLC6A3—NRF2 pathway—KEAP1—kidney cancer	8.95e-05	0.0103	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—HNF1B—kidney cancer	8.85e-05	0.0102	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Xenobiotics—CYP1A1—kidney cancer	8.71e-05	0.01	CbGpPWpGaD
Dexmethylphenidate—Feeling abnormal—Doxorubicin—kidney cancer	8.66e-05	0.00014	CcSEcCtD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—KCNMA1—kidney cancer	8.62e-05	0.00991	CbGpPWpGaD
Dexmethylphenidate—Gastrointestinal pain—Doxorubicin—kidney cancer	8.59e-05	0.000139	CcSEcCtD
Dexmethylphenidate—CYP2D6—Tamoxifen metabolism—CYP1A1—kidney cancer	8.37e-05	0.00963	CbGpPWpGaD
Dexmethylphenidate—Urticaria—Doxorubicin—kidney cancer	8.35e-05	0.000135	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Doxorubicin—kidney cancer	8.31e-05	0.000134	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Doxorubicin—kidney cancer	8.31e-05	0.000134	CcSEcCtD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	8.26e-05	0.0095	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—ACY1—kidney cancer	8.01e-05	0.00921	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL13—kidney cancer	7.95e-05	0.00914	CbGpPWpGaD
Dexmethylphenidate—Hypersensitivity—Doxorubicin—kidney cancer	7.74e-05	0.000125	CcSEcCtD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—JUND—kidney cancer	7.73e-05	0.00889	CbGpPWpGaD
Dexmethylphenidate—Asthenia—Doxorubicin—kidney cancer	7.54e-05	0.000122	CcSEcCtD
Dexmethylphenidate—Pruritus—Doxorubicin—kidney cancer	7.43e-05	0.00012	CcSEcCtD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	7.28e-05	0.00837	CbGpPWpGaD
Dexmethylphenidate—Diarrhoea—Doxorubicin—kidney cancer	7.19e-05	0.000116	CcSEcCtD
Dexmethylphenidate—SLC6A4—NRF2 pathway—SLC5A5—kidney cancer	7.09e-05	0.00815	CbGpPWpGaD
Dexmethylphenidate—Dizziness—Doxorubicin—kidney cancer	6.95e-05	0.000112	CcSEcCtD
Dexmethylphenidate—SLC6A4—NRF2 pathway—SLC2A1—kidney cancer	6.85e-05	0.00787	CbGpPWpGaD
Dexmethylphenidate—Vomiting—Doxorubicin—kidney cancer	6.68e-05	0.000108	CcSEcCtD
Dexmethylphenidate—Rash—Doxorubicin—kidney cancer	6.63e-05	0.000107	CcSEcCtD
Dexmethylphenidate—Dermatitis—Doxorubicin—kidney cancer	6.62e-05	0.000107	CcSEcCtD
Dexmethylphenidate—Headache—Doxorubicin—kidney cancer	6.58e-05	0.000106	CcSEcCtD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—CYP1A1—kidney cancer	6.47e-05	0.00743	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	6.45e-05	0.00742	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—RYR1—kidney cancer	6.44e-05	0.00741	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—EGR1—kidney cancer	6.36e-05	0.00731	CbGpPWpGaD
Dexmethylphenidate—Nausea—Doxorubicin—kidney cancer	6.24e-05	0.000101	CcSEcCtD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC5A5—kidney cancer	6.1e-05	0.00701	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—EGR1—kidney cancer	6.03e-05	0.00693	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC2A1—kidney cancer	5.89e-05	0.00677	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—GSTP1—kidney cancer	5.71e-05	0.00656	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—RYR1—kidney cancer	5.71e-05	0.00656	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—EGR1—kidney cancer	5.47e-05	0.00628	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC5A5—kidney cancer	5.4e-05	0.00621	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—GSTM1—kidney cancer	5.25e-05	0.00603	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC2A1—kidney cancer	5.22e-05	0.006	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—KCNMA1—kidney cancer	5.05e-05	0.00581	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—EGR1—kidney cancer	4.92e-05	0.00566	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—GSTP1—kidney cancer	4.91e-05	0.00564	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—ACHE—kidney cancer	4.88e-05	0.00561	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—EGR1—kidney cancer	4.84e-05	0.00557	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	4.55e-05	0.00523	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—GSTM1—kidney cancer	4.51e-05	0.00519	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—ALDH1A1—kidney cancer	4.39e-05	0.00504	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—GSTP1—kidney cancer	4.35e-05	0.005	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—BCHE—kidney cancer	4.25e-05	0.00489	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—HIF1A—kidney cancer	4.19e-05	0.00482	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—GSTM1—kidney cancer	4e-05	0.00459	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	3.84e-05	0.00442	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—ACHE—kidney cancer	3.74e-05	0.0043	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	3.71e-05	0.00427	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.7e-05	0.00425	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.7e-05	0.00425	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.7e-05	0.00425	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	3.62e-05	0.00416	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	3.57e-05	0.0041	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	3.4e-05	0.00391	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	3.29e-05	0.00378	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.28e-05	0.00377	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.28e-05	0.00377	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.28e-05	0.00377	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—BCHE—kidney cancer	3.26e-05	0.00374	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.93e-05	0.00337	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.7e-05	0.0031	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—GSTT1—kidney cancer	2.58e-05	0.00296	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—JUN—kidney cancer	2.53e-05	0.00291	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	2.51e-05	0.00289	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—PTGS1—kidney cancer	2.42e-05	0.00278	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—VEGFA—kidney cancer	2.21e-05	0.00254	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.19e-05	0.00251	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—BRAF—kidney cancer	2.17e-05	0.00249	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—JUN—kidney cancer	2.07e-05	0.00237	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—PTEN—kidney cancer	2e-05	0.0023	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.95e-05	0.00224	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.89e-05	0.00217	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—RAF1—kidney cancer	1.81e-05	0.00208	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—GSTP1—kidney cancer	1.79e-05	0.00205	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	1.76e-05	0.00203	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.73e-05	0.00199	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.67e-05	0.00192	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—BRAF—kidney cancer	1.66e-05	0.00191	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—GSTM1—kidney cancer	1.64e-05	0.00189	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	1.62e-05	0.00186	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	1.56e-05	0.00179	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	1.54e-05	0.00177	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.49e-05	0.00171	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—RAF1—kidney cancer	1.39e-05	0.0016	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ACY1—kidney cancer	1.37e-05	0.00157	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—TP53—kidney cancer	1.36e-05	0.00157	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.32e-05	0.00152	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.24e-05	0.00143	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PDHB—kidney cancer	1.16e-05	0.00134	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—POMC—kidney cancer	1.16e-05	0.00133	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CCBL1—kidney cancer	1.09e-05	0.00126	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—MAPK1—kidney cancer	9.52e-06	0.00109	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PPAT—kidney cancer	9.49e-06	0.00109	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GLIPR1—kidney cancer	9.49e-06	0.00109	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—APRT—kidney cancer	8.82e-06	0.00101	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—FH—kidney cancer	8.82e-06	0.00101	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—RAF1—kidney cancer	8.42e-06	0.000968	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GPC3—kidney cancer	8.3e-06	0.000954	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CA2—kidney cancer	8.07e-06	0.000928	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ALAD—kidney cancer	7.87e-06	0.000904	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ST3GAL2—kidney cancer	7.68e-06	0.000882	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ALDH1A1—kidney cancer	7.5e-06	0.000863	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—RAF1—kidney cancer	7.46e-06	0.000858	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PGK1—kidney cancer	7.19e-06	0.000827	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SLC5A3—kidney cancer	7.19e-06	0.000827	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—LDHB—kidney cancer	7.05e-06	0.000811	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CA9—kidney cancer	6.12e-06	0.000703	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CRABP1—kidney cancer	5.2e-06	0.000598	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ITPR2—kidney cancer	4.84e-06	0.000556	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ACHE—kidney cancer	4.41e-06	0.000507	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GSTT1—kidney cancer	4.41e-06	0.000507	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SCARB1—kidney cancer	4.17e-06	0.00048	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PTGS1—kidney cancer	4.13e-06	0.000475	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PSMD7—kidney cancer	4.05e-06	0.000466	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—BCHE—kidney cancer	3.84e-06	0.000442	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SLC5A5—kidney cancer	3.79e-06	0.000436	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SLC2A1—kidney cancer	3.66e-06	0.000421	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GSTP1—kidney cancer	3.06e-06	0.000351	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ABCB1—kidney cancer	2.89e-06	0.000333	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GSTM1—kidney cancer	2.81e-06	0.000323	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.66e-06	0.000306	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—POMC—kidney cancer	1.99e-06	0.000228	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PTGS2—kidney cancer	1.58e-06	0.000182	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PTEN—kidney cancer	1.38e-06	0.000159	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PIK3CA—kidney cancer	9.74e-07	0.000112	CbGpPWpGaD
